Intelligence platform AcuityMD announced data revealing that the majority – nearly 60% – of all endoscopic colorectal procedures in the U.S. are now performed in ASCs. It states that ASCs handled nearly nine million endoscopic colorectal procedures in 2024, representing a 50% volume increase since 2018.
Rates vary by region, however. AcuityMD finds that nearly 70% of endoscopic colorectal procedures in the South are performed in ASCs, with 65% in the West, 55% in the Northeast, and 40% in the Midwest.
AcuityMD says the data “highlights the need to continue increasing access to and raising awareness of the importance of these procedures in ASCs, specifically in geographies where rates lag behind. Not only will this help more patients benefit from early detection and prompt treatment, but it will also provide economic relief to the nation’s healthcare system, as ASCs are often at least 60% less expensive than hospitals. Early detection through ASC screening also prevents costlier care later. Colorectal diseases caught late often require complex laparoscopic procedures, 64% of which are still performed in hospitals rather than lower-cost ASCs.”
Lee Smith, AcuityMD’s co-founder and vice president of customer experience, says that as more procedures migrate to ASCs, healthcare organizations that “don’t follow that volume risk losing visibility into a fast-growing segment of the market – and the physicians driving it. Given this shift, it’s important for companies to quickly identify relevant ASC market opportunities. Physicians at ASCs often open the door to larger opportunities at more hospitals nationwide.”
Take a more granular look at AcuityMD's data here.
